DOG1.1 is a recently described mouse monoclonal antibody reported to have superior sensitivity and specificity compared with KIT (CD117 Small subset of mesenchymal tumors like leiomyosarcoma and synovial sarcoma also show DOG1 positivity. This evidence concerns the gene KIT and leiomyosarcoma.